ArticleCancer discovery2014

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.

Eliezer M Van Allen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.